Structured Discharge and Follow-up Protocol for COPD Patients Receiving LTOT and NIV

Summary

Readmission to hospital is one of the most important problems in chronic obstructive pulmonary disease (COPD) patients who developed chronic respiratory failure. Patients receiving long-term oxygen therapy (LTOT) and noninvasive ventilation (NIV) constitute the most vulnerable group because of the need for comprehensive care. However, because of lack of health care support systems in Turkey, many advanced COPD patients are hospitalized due to preventable problems such as insufficient knowledge about the therapies, nonadherence to therapy and technical issues related to LTOT/NIV equipment. The aim of this multicenter randomized trial is to find out whether a structured discharge and follow-up protocol reduce the rate of unplanned, COPD-related hospital readmissions over 90 days in patients receiving LTOT or NIV.

Conditions

• COPD Exacerbation
• Noninvasive Ventilation
• Long Term Oxygen Therapy
• Chronic Respiratory Failure

Interventions

OTHER

Protocol for structured discharge and follow-up

Sponsors & Collaborators

• Celal Bayar University

  collaborator OTHER

• Ege University

  collaborator OTHER

• Gazi University

  collaborator OTHER

• Duzce University

  collaborator OTHER

• Cukurova University

  collaborator OTHER

• Ataturk University

  collaborator OTHER

• Uludag University

  collaborator OTHER

• Atatürk Chest Diseases and Chest Surgery Training and Research Hospital

  collaborator OTHER

• Istanbul Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital

  collaborator OTHER

• T.C. ORDU ÜNİVERSİTESİ

  collaborator OTHER

• Hacettepe University

  collaborator OTHER

• Turkish Directorate General of Public Health

  collaborator UNKNOWN

• Istanbul University - Cerrahpasa

  collaborator OTHER

• Diskapi Yildirim Beyazit Education and Research Hospital

  collaborator OTHER_GOV

• Dokuz Eylul University

  lead OTHER

Principal Investigators

• BEGUM ERGAN, MD · Dokuz Eylul University

• TUGBA GOKTALAY, MD · Celal Bayar University

• PINAR ERGUN, MD · Health Sciences University Ataturk Chest Diseases and Chest Surgery Hospital

• ALEV GURGUN, MD · Ege University

• METIN AKGUN, MD · Ataturk University

• NURDAN KOKTURK, MD · Gazi University

• EZGI OZYILMAZ, MD · Cukurova University

• ASLI DILEKTASLI, MD · Uludag University

• BIRSEN OCAKLI, MD · Health Sciences University Sureyyapasa Chest Diseases and Chest Surgery Hospital

• ONER BALBAY, MD · Duzce University

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

40 Years

Max Age

85 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2016-11-07

Primary Completion

2019-08-31

Completion

2019-08-31

Countries

• Turkey (Türkiye)

Study Locations